Cardiomyopathy and Frequent Monomorphic PVC : Which One Comes First?

Anita Surya Santoso, Djanggan Sargowo, Ardian Rizal

Abstract


A 28-year-old male wasaadmittedto hospitalwwith chief complaint chestadiscomfort. There were symptoms of dyspnea on effort and palpitation before. He had a history of alcoholics for more than five years. The ECG showed frequent Premature Ventricular Complex (PVC) and recommended to have ambulatory Holter monitoring with conclusion frequent monomorphic right ventricle outflow tract (RVOT) origin PVC. Echocardiography indicated a decrease in left ventricular (LV) function, LV dilatation, and global hypokinetic. Cardiac Magnetic Resonance Imaging (CMR) was performed, and there was no “edema”and myocardium fibrosis. It is essential to analyze which comes first, arrhythmia induced cardiomyopathy (AIC), or cardiomyopathy induced arrhythmia to have direct treatment. From the collected data, we conclude that the frequent RVOT origin PVC induced cardiomyopathy and catheter ablation is the definitive therapy.


Keywords


cardiomyopathy, frequent monomorphic PVC, AIC, ablation

Full Text:

PDF

References


Japp AG, Gulati A, Cook SA, Cowie MR, Prasad SK. The diagnosis and evaluation of dilated cardiomyopathy. Journal of the American College of Cardiology. 2016 Jun 28;67(25):2996-3010.

Centurión OA, Alderete JF, Torales JM, García LB, Scavenius KE, Miño LM. Myocardial fibrosis as a pathway of prediction of ventricular arrhythmias and sudden cardiac death in patients with non-ischemic dilated cardiomyopathy. Critical pathways in cardiology. 2019 Jun 1;18(2):89-97.

Sulaiman S, Yousef N, Mehanni MM, Sundararajan S, Wingert R, Wingert M, Mohammed A, Jahangir A. Burden of arrhythmia and electrophysiologic procedures in alcoholic cardiomyopathy hospitalizations. International journal of cardiology. 2020 Jan 28.

Gopinathannair R, Etheridge SP, Marchlinski FE, Spinale FG, Lakkireddy D, Olshansky B. Arrhythmia-induced cardiomyopathies: mechanisms, recognition, and management. Journal of the American College of Cardiology. 2015 Oct 13;66(15):1714-28.

Puntmann VO, Carr-White G, Jabbour A, Yu CY, Gebker R, Kelle S, Hinojar R, Doltra A, Varma N, Child N, Rogers T. T1-mapping and outcome in non-ischemic cardiomyopathy: all-cause mortality and heart failure. JACC: Cardiovascular Imaging. 2016 Jan 1;9(1):40-50.

Peters S, Kumar S, Elliott P, Kalman JM, Fatkin D. Arrhythmic genotypes in familial dilated cardiomyopathy: implications for genetic testing and clinical management. Heart, Lung and Circulation. 2019 Jan 1;28(1):31-8.

Vaseghi M, Hu TY, Tung R, Vergara P, Frankel DS, Di Biase L, Tedrow UB, Gornbein JA, Yu R, Mathuria N, Nakahara S. Outcomes of catheter ablation of ventricular tachycardia based on etiology in non-ischemic heart disease: an international ventricular tachycardia ablation center collaborative study. JACC: Clinical Electrophysiology. 2018 Sep 17;4(9):1141-50.

Zeppenfeld K. Ventricular tachycardia ablation in non-ischemic cardiomyopathy. JACC: Clinical Electrophysiology. 2018 Sep 17;4(9):1123-40.

Patel AR, Kramer CM. Role of cardiac magnetic resonance in the diagnosis and prognosis of non-ischemic cardiomyopathy. JACC: Cardiovascular Imaging. 2017 Oct 2;10(10 Part A):1180-93.

Ware JS, Amor-Salamanca A, Tayal U, Govind R, Serrano I, Salazar-Mendiguchía J, García-Pinilla JM, Pascual-Figal DA, Nuñez J, Guzzo-Merello G, Gonzalez-Vioque E. Genetic etiology for alcohol-induced cardiac toxicity. Journal of the American College of Cardiology. 2018 May 14;71(20):2293-302.

Dukkipati SR, Koruth JS, Choudry S, Miller MA, Whang W, Reddy VY. Catheter ablation of ventricular tachycardia in structural heart disease: indications, strategies, and outcomes—Part II. Journal of the American College of Cardiology. 2017 Dec 4;70(23):2924-41

Gopinathannair R, Etheridge SP, Marchlinski FE, Spinale FG, Lakkireddy D, Olshansky B. Arrhythmia-induced cardiomyopathies: mechanisms, recognition, and management. Journal of the American College of Cardiology. 2015 Oct 13;66(15):1714-28.

Disertori M, Masè M, Ravelli F. Myocardial fibrosis predicts ventricular tachyarrhythmias. Trends in cardiovascular medicine. 2017 Jul 1;27(5):363-72.

Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, Dubourg O, Kühl U, Maisch B, McKenna WJ, Monserrat L. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. European heart journal. 2008 Jan 1;29(2):270-6.

Muser D, Santangeli P, Castro SA, Pathak RK, Liang JJ, Hayashi T, Magnani S, Garcia FC, Hutchinson MD, Supple GG, Frankel DS. Long-term outcome after catheter ablation of ventricular tachycardia in patients with non-ischemic dilated cardiomyopathy. Circulation: Arrhythmia and Electrophysiology. 2016 Oct;9(10):e004328.




DOI: https://doi.org/10.21776/ub.hsj.2022.003.03.8

Refbacks

  • There are currently no refbacks.


Copyright (c) 2022 Anita Surya Santoso

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.